• MTT as a Benchmark In Vitro Cell Proliferation Assay Reagent

  2026-07-06

  MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide) stands out as a high-purity, NADH-dependent oxidoreductase substrate for robust colorimetric cell viability assays. APExBIO’s MTT empowers precise workflow optimization across diverse applications, from angiogenesis research to translational oncology, with actionable troubleshooting and protocol insights.

• Cy3 NHS ester (non-sulfonated): Technical Guide for Protein

  2026-07-06

  Cy3 NHS ester (non-sulfonated) provides a reliable solution for covalent labeling of proteins, peptides, and oligonucleotides at primary amines, supporting sensitive detection workflows in biomedical imaging and quantitative assays. It is best suited for protocols where organic co-solvents are acceptable, and is not optimal for highly sensitive or delicate proteins that require fully aqueous labeling conditions.

• Angiotensin Peptides Potentiate SARS-CoV-2 Spike–AXL Binding

  2026-07-05

  This study reveals that naturally occurring angiotensin peptides, including Angiotensin III, can substantially enhance the binding affinity of the SARS-CoV-2 spike protein to the AXL receptor. These findings highlight a novel intersection between RAAS peptide biology and viral entry mechanisms, with implications for understanding COVID-19 pathogenesis and potential therapeutic targeting.

• Br-DAPI: Advancing DNA Quantification in Diabetic Heart Mode

  2026-07-04

  Br-DAPI from APExBIO sets a new benchmark for sensitive DNA quantification in both live and fixed cell assays, empowering cardiovascular researchers to dissect molecular mechanisms in diabetic cardiomyopathy. Its robust fluorescence amplification and cellular permeability streamline advanced imaging and enable reproducible workflows in translational cardiac research.

• Estramustine Compliance and Degarelix-Based Neoadjuvant Ther

  2026-07-03

  This prospective clinical study demonstrates that strict dose compliance with estramustine phosphate, when combined with neoadjuvant degarelix acetate, predicts reduced biochemical recurrence in patients with very high-risk prostate cancer undergoing robot-assisted radical prostatectomy. The findings inform risk-adapted approaches to chemohormonal therapy and highlight the importance of managing adverse events for optimal clinical outcomes.

• RRP Extracts Restore Hepatic Lipid Metabolism in Ischemia-Re

  2026-07-03

  The reference study demonstrates that Radix Rehmanniae Praeparata (RRP) extracts mitigate hepatic ischemia-reperfusion injury (HIRI) by restoring lipid metabolism in hepatocytes. By dissecting the roles of AMPK activation, SREBP2 inhibition, and LXRα-mediated cholesterol efflux, the research provides mechanistic insights into liver protection and potential new intervention targets.

• Bafilomycin C1 in Deep Phenotypic Screening: A Next-Gen Assa

  2026-07-02

  Explore how Bafilomycin C1, a potent vacuolar H+-ATPases inhibitor, is reshaping next-generation phenotypic screening and autophagy assays. This article reveals advanced strategies and unique insights for leveraging Bafilomycin C1 in high-content functional genomics.

• Reversine (A3760): Technical Guide for Aurora Kinase Inhibit

  2026-07-02

  Reversine (SKU A3760) is a small molecule Aurora kinase inhibitor widely used to study mitotic regulation, cell proliferation, and apoptosis in cancer biology research. It is most suitable for in vitro and in vivo workflows targeting Aurora kinase signaling pathways, with optimized protocols for solubility and cell-based applications. This reagent is not suitable for diagnostic or medical use and should not be used in workflows requiring aqueous solubility.

• 1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine in Src Kinase P

  2026-07-01

  Leverage 1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine (PP 3) as a precision negative control for kinase inhibitor studies, ensuring specificity and data clarity in Src kinase signaling pathway research. This guide translates the latest vascular ROS signaling insights into actionable protocol enhancements and troubleshooting strategies.

• A23187, Free Acid: Precision Calcium Ionophores in Translati

  2026-07-01

  Explore how A23187, free acid empowers mechanistic research into calcium signaling, apoptosis, and cell physiology. This thought-leadership article bridges molecular insights and workflow strategy, guiding translational researchers in harnessing calcium ionophores for reproducible, clinically relevant discoveries. With evidence from primary literature and expert workflow integration, we chart a path from in vitro discovery to translational relevance.

• GPR107 Deficiency Accelerates Diabetic Nephropathy via Ca2+

  2026-06-30

  Xu et al. (2025) illuminate the mechanistic role of GPR107 in diabetic nephropathy, showing that its deficiency exacerbates glomerular damage by dysregulating AT1R endocytosis and calcium signaling in podocytes. These findings offer new insight into ECM remodeling in diabetic kidneys and highlight GPR107 as a potential therapeutic target.

• PTH (1-34) (Human): Precision Tools for Bone and Kidney Mode

  2026-06-30

  Explore how Parathyroid hormone (1-34) (human) advances translational research by bridging mechanistic insight and experimental rigor for bone metabolism and kidney modeling. This thought-leadership article integrates the latest assembloid platform findings, competitive analysis, and actionable guidance for researchers aiming for high-fidelity disease models.

• DNase I (RNase-free): Enabling Precision Chromatin and Stem

  2026-06-29

  Explore how DNase I (RNase-free) advances chromatin and cancer stem cell research through precise DNA digestion and contaminant-free RNA workflows. This in-depth guide reveals unique assay strategies and protocol insights unavailable elsewhere.

• L-Glutathione Reduced in Redox Control: Workflows & Solution

  2026-06-29

  L-Glutathione Reduced stands out as a versatile antioxidant for researchers tackling complex redox, metabolic, and detoxification pathways. Discover how optimized protocols and troubleshooting insights can transform your oxidative stress and GST workflows using APExBIO's high-purity formulation.

• Enduring Potentiation of CFTR by VX-770 in Primary Airway Ep

  2026-06-28

  This study demonstrates that VX-770 (ivacaftor) exerts a durable, long-lasting potentiation on the CFTR chloride channel in primary human airway epithelial cultures, even after brief or low-dose exposure. These findings have important implications for understanding CFTR modulator therapy dynamics and experimental modeling of airway ion transport.

11524 records 1/769 page Next 12345 下5页 Last page